Grace Therapeutics (GRCE) Institutional Ownership $2.97 +0.01 (+0.34%) As of 08/6/2025 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Grace Therapeutics (NASDAQ:GRCE)CurrentInstitutional OwnershipPercentage6.08%Number ofInstitutional Buyers(last 12 months)4TotalInstitutional Inflows(last 12 months)$4.29MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$575.83K Get GRCE Insider Trade Alerts Want to know when executives and insiders are buying or selling Grace Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data GRCE Institutional Buying and Selling by Quarter Grace Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails7/29/2025 AIGH Capital Management LLC1,128,497$3.35M1.5%-14.7%8.160% 7/15/2025 Palumbo Wealth Management LLC48,541$144K0.0%N/A0.351% 5/16/2025ADAR1 Capital Management LLC343,512$783K0.1%N/A3.388% 5/15/2025Nantahala Capital Management LLC1,178,203$2.69M0.1%N/A11.619% 5/14/2025Stonepine Capital Management LLC294,550$666K0.6%N/A2.905% (Data available from 1/1/2016 forward) GRCE Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of GRCE shares? During the previous two years, the following institutional investors and hedge funds held shares of Grace Therapeutics shares: AIGH Capital Management LLC ($3.35M), Nantahala Capital Management LLC ($2.69M), ADAR1 Capital Management LLC ($783K), and Stonepine Capital Management LLC ($666K), Palumbo Wealth Management LLC ($144K).Learn more on Grace Therapeutics' institutional investors. What percentage of Grace Therapeutics' stock is owned by institutional investors? 6.08% of Grace Therapeutics' stock is owned by institutional investors. Learn more on GRCE's institutional investor holdings. Which institutional investors have been buying Grace Therapeutics' stock? The following institutional investors have purchased Grace Therapeutics' stock in the last 24 months: Nantahala Capital Management LLC ($1.18M), ADAR1 Capital Management LLC ($343.51K), Stonepine Capital Management LLC ($294.55K), and Palumbo Wealth Management LLC ($48.54K). How much institutional buying is happening at Grace Therapeutics? Institutional investors have bought a total of 1,864,806 shares in the last 24 months. This purchase volume represents approximately $4.29M in transactions. Which of Grace Therapeutics' major shareholders have been selling company stock? The following institutional investors have sold Grace Therapeutics stock in the last 24 months: AIGH Capital Management LLC ($193.88K). How much institutional selling is happening at Grace Therapeutics? Institutional investors have sold a total of 193,882 shares in the last 24 months. This volume of shares sold represents approximately $575.83K in transactions. Related Companies Enanta Pharmaceuticals Major Shareholders Kyverna Therapeutics Major Shareholders Black Diamond Therapeutics Major Shareholders Lifevantage Major Shareholders Alector Major Shareholders BioAge Labs Major Shareholders Nuvectis Pharma Major Shareholders Puma Biotechnology Major Shareholders Contineum Therapeutics Major Shareholders Nkarta Major Shareholders This page (NASDAQ:GRCE) was last updated on 8/7/2025 by MarketBeat.com Staff From Our PartnersBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Grace Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Grace Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GRCE Stock Alerts